Role of Serum (B/A) Ratio Compared to (TSB) for Early Prediction of Bilirubin-induced Neurological Dysfunction (BIND).

ConditionHyperbilirubinemia, Neonatal

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age1-28

Sponsoralaa aboelhassan mohamed aboelhassan

About this trial

The aim of this study is to evaluate serum bilirubin/albumin (B/A) ratio compared to total serum bilirubin (TSB) for early prediction of bilirubin-induced neurological dysfunction (BIND).

Eligibility criteria

Qualifiers

Age: from 1 to 28 day.

Full term and preterm babies.

Both sexes.

Disqualifiers

Conjugated hyperbilirubinemia.

Perinatal asphyxia.

Patients with encephalopathy due to causes other than hyperbilirubinemia.

Severe birth defects or congenital anomalies.

Trial design

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Locations

This trial has no locations

Sponsors and collaborators

alaa aboelhassan mohamed aboelhassan

Lead sponsor

Assiut University

Sponsor institution

Source ClinicalTrials.gov